More than 20% of newborn infants in the United States are fed formula to supplement breastfeeding in their first 2 days. Most hospitals that provide pasteurized donor human milk (PDHM) for supplemental feeding limit its use to infants <32 weeks’ gestation or <1,500 g at birth. Cost is one perceived barrier to PDHM use among late preterm or full-term infants that do not meet premature age or low birth weight criteria.
Objectives:
The aim of the project was to identify and describe the current literature on the financial feasibility of providing donor breast milk instead of formula among a wider population.
Methods:
We performed an integrative review using The Johns Hopkins Evidence-Based Practice Model framework for article appraisal. The search used PubMed, CINAHL and JBI electronic databases for articles from 2011 to 2022.
Results:
From 536 articles retrieved, five met criteria for inclusion. Analyzed articles reported on trends, indications, costs, and accessibility of PDHM. Results revealed various methods of incorporating PDHM in their operational budget.
Conclusions:
Use of PDHM instead of the formula is increasing for supplementation. Facilities using PDHM beyond these limits have included its costs in their operational budget. This article reveals the multifactorial elements that contribute to the cost of PDHM, thus underscoring the lack of evidence demonstrating cost as a barrier to providing PDHM for infants >32 weeks or >1,500 g. More studies are needed to identify the cost-benefit ratio of the use of PDHM for this population.
MeekJY, NobleL, Section on Breastfeeding. Policy statement: Breastfeeding and the use of human milk. Pediatrics, 2022; 150(1):e2022057988; doi: 10.1542/peds.2022-057988
6.
VictoraCG, BahlR, BarrosAJD, et al.Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. The. Lancet, 2016; 387(10017):475–490; doi: 10.1016/S0140-6736(15)01024-7
7.
DiazLE, YeeLM, FeinglassJ. Rates of breastfeeding initiation and duration in the United States: Data insights from the 2016–2019 Pregnancy Risk Assessment Monitoring System. Front Public Health, 2023; 11:1256432; doi: 10.3389/fpubh.2023.1256432
8.
ChiangKV, LiR, AnsteyEH, et al.Racial and Ethnic Disparities in Breastfeeding Initiation—United States, 2019. MMWR Morb Mortal Wkly Rep, 2021; 70(21):769–774. Available from: https://www.cdc.gov/mmwr/volumes/70/wr/mm7021a1.htm [Last accessed: June1, 2024].
LucasA, ColeTJ. Breast milk and neonatal necrotising enterocolitis. Lancet, 1990; 336(8730):1519–1523; doi: 10.1016/0140-6736(90)93304-8
11.
DanielsS, CorkinsM, de FerrantiS, et al.Donor human milk for the high-risk infant: Preparation, safety, and usage options in the United States. Pediatrics, 2017; 139(1):e20163440; doi: 10.1542/peds.2016-3440
12.
RoseAT, MillerER, ButlerM, et al.US state policies for Medicaid coverage of donor human milk. J Perinatol, 2022; 42(6):829–834; doi: 10.1038/s41372-022-01375-9
Feldman-WinterL, WareJ, SchreckP, et al.ABM position statement: Recommendation for exclusive breastfeeding: Avoidance of underfeeding and overfeeding (October 2024). Breastfeeding Medicine, 2025; 20(2):81–84; doi: 10.1089/bfm.2024.85389.bess
16.
CristofaloEA, SchanlerRJ, BlancoCL, et al.Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr, 2013; 163(6):1592–1595.e1; doi: 10.1016/j.jpeds.2013.07.011
17.
SullivanS, SchanlerRJ, KimJH, et al.An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr, 2010; 156(4):562–567.e1; doi: 10.1016/j.jpeds.2009.10.040
18.
BoundyEO, PerrineCG, NelsonJM, et al.Disparities in Hospital-Reported Breast Milk Use in Neonatal Intensive Care Units—United States, 2015. MMWR Morb Mortal Wkly Rep, 2017; 66(48):1313–1317. https://www.cdc.gov/mmwr/volumes/66/wr/mm6648a1.htm [Last accessed: June 1, 2024].
19.
BelfortMB, DrouinK, RileyJF, et al.Prevalence and trends in donor milk use in the well-baby nursery: A Survey of Northeast United States Birth Hospitals. Breastfeed Med, 2018; 13(1):34–41; doi: 10.1089/bfm.2017.0147
20.
McCuneS, PerrinMT. Donor human milk use in populations other than the preterm infant: A systematic scoping review. Breastfeed Med, 2021; 16(1):8–20; doi: 10.1089/bfm.2020.0286
21.
PaganoF, GaetaE, MorlinoF, et al.Long-term benefits of exclusive human milk diet in small for gestational age neonates: A systematic review of the literature. Ital J Pediatr, 2024; 50(1):88; doi: 10.1186/s13052-024-01648-3
DangD, DearholtS, BissettK, et al.Johns Hopkins Evidence-Based Practice for Nurses and Healthcare Professionals, Fourth Edition. Sigma Theta Tau International; 2021.
24.
PageMJ, McKenzieJE, BossuytPM, et al.Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. J Clin Epidemiol, 2021; 134:103–112; doi: 10.1186/s13643-021-01626-4
25.
BaiY, KuscinJ. The current state of donor human milk use and practice. J Midwifery Womens Health, 2021; 66(4):478–485; doi: 10.1111/jmwh.13244
26.
ParkerMG, BurnhamLA, KerrS, et al.Prevalence and predictors of donor milk programs among U.S. advanced neonatal care facilities. J Perinatol, 2020; 40(4):672–680; doi: 10.1038/s41372-020-0620-6
27.
PonnapakkamA, ReesD, GallupMC, et al.Supplementation-based hypoglycemia guidelines including donor breast milk reduce NICU admission. J Perinatol, 2021; 41(8):2088–2094; doi: 10.1038/s41372-021-01069-8
28.
SenS, BenjaminC, RileyJ, et al.Donor milk utilization for healthy infants: Experience at a single academic center. Breastfeed Med, 2018; 13(1):28–33; doi: 10.1089/bfm.2017.0096
29.
SpatzDL, RobinsonAC, FrohEB. Cost and use of pasteurized donor human milk at a children’s hospital. J Obstet Gynecol Neonatal Nurs, 2018; 47(4):583–588; doi: 10.1016/j.jogn.2017.11.004
